The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Bristol-Myers Squibb; Cellectis; Daiichi Sankyo; ImmunoGen; Incyte; Janssen; Jazz Pharmaceuticals; Menarini; Novartis; Otsuka; Pfizer; SERVIER; Shire; Sunesis Pharmaceuticals
Research Funding - Amgen (Inst); Incyte (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst); Pfizer (Inst); SERVIER (Inst)
 
Consulting or Advisory Role - Alexion Pharmaceuticals; Amgen; Bristol-Myers Squibb; Gilead Sciences; Janssen; Merck Sharp & Dohme; Novartis; Pfizer
Travel, Accommodations, Expenses - Alexion Pharmaceuticals; Amgen; Bristol-Myers Squibb; Gilead Sciences; Incyte; Janssen; Merck Sharp & Dohme; Novartis; Pfizer
CC-486 is safe and well-tolerated as maintenance therapy in elderly patients (≥75 years) with acute myeloid leukemia (AML) in first remission following induction chemotherapy: Results from the phase III QUAZAR AML-001 trial.
 
Farhad Ravandi
Honoraria - Abbvie/Genentech; Agios; Amgen; Astellas Pharma; Celgene; Orsenix; Pfizer; Seagen; Sunesis Pharmaceuticals
Consulting or Advisory Role - Abbvie/Genentech; Agios; Amgen; Astellas Pharma; Celgene; Jazz Pharmaceuticals; Orsenix; Seagen; Sunesis Pharmaceuticals
Research Funding - Amgen; Bristol-Myers Squibb; Cellerant; Macrogenics; Merck; Seagen; Selvita; Sunesis Pharmaceuticals; Xencor
 
Andrew Wei
Honoraria - Abbvie/Genentech; Amgen; Celgene; Janssen Oncology; Novartis; Pfizer; Roche; SERVIER
Consulting or Advisory Role - Abbvie/Genentech; Amgen; Celgene; Macrogenics; Novartis; Pfizer; SERVIER
Speakers' Bureau - Abbvie/Genentech; Amgen; Celgene; Novartis
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Celgene (Inst); Novartis (Inst); Servier (Inst)
Patents, Royalties, Other Intellectual Property - AW is a former employee of the Walter and Eliza Hall Institute which receives milestone and royalty payments related to venetoclax, and is eligible for benefits related to these payments. AW receives payments from WEHI related to venetoclax
Travel, Accommodations, Expenses - Abbvie; Amgen; Celgene; Janssen Oncology; Novartis; Pfizer; Servier
 
Hartmut Dohner
Honoraria - Abbvie; Celgene; Jazz Pharmaceuticals; Novartis
Consulting or Advisory Role - Abbvie; Agios; Amgen; Astellas Pharma; Astex Pharmaceuticals; Celgene; Jazz Pharmaceuticals; Roche
Research Funding - Amgen (Inst); Arog (Inst); Bristol-Myers Squibb (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst); Pfizer (Inst); Sunesis Pharmaceuticals (Inst)
 
Hervé Dombret
No Relationships to Disclose
 
Gert J. Ossenkoppele
Consulting or Advisory Role - Agen; Agios; Astellas Pharma; Bristol-Myers Squibb; Daiichi Sankyo; Genentech; Jazz Pharmaceuticals; Johnson & Johnson; Novartis; Roche
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); Johnson & Johnson (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Roche
 
Michael Pfeilstöcker
Consulting or Advisory Role - Abbvie; Astellas Pharma; Celgene
Travel, Accommodations, Expenses - Celgene
 
Felicitas Thol
Honoraria - Novartis
Consulting or Advisory Role - Abbvie; Daiichi Sankyo
 
Georg Feldman
Consulting or Advisory Role - Bristol-Myers Squibb; Chugai Pharma; Roche
 
Maria Teresa Voso
Honoraria - Bristol-Myers Squibb; Roche
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst)
 
Paula Marlton
Honoraria - Abbvie; Celgene; Janssen-Cilag; Novartis; Roche
Consulting or Advisory Role - Abbvie; Astellas Pharma; Celgene; Janssen-Cilag; Novartis; Roche
Travel, Accommodations, Expenses - Roche
 
Michael Harvey
No Relationships to Disclose
 
Valeria Santini
Honoraria - Bristol-Myers Squibb; Johnson & Johnson; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Menarini; Novartis; Pfizer; Takeda
 
Luana Fianchi
Consulting or Advisory Role - Bristol-Myers Squibb; Sanofi
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Anna Candoni
No Relationships to Disclose
 
Ignazia La Torre
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Barry Skikne
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Keshava Kumar
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Qian Dong
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
C. L. Beach
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Gail J. Roboz
Consulting or Advisory Role - Abbvie; Actinium Pharmaceuticals; Agios; Amgen; Amphivena; argenx; Array BioPharma; Astellas Pharma; Astex Pharmaceuticals; Bayer; Bayer; Celgene; Celltrion; Daiichi Sankyo; Eisai; Genentech/Roche; Genoptix; Janssen; Jazz Pharmaceuticals; MedImmune; MEI Pharma; Novartis; Orsenix; Otsuka; Pfizer; Roche; Sandoz; Takeda; Trovagene
Research Funding - Abbvie (Inst); Agios (Inst); amphivena (Inst); Astex Pharmaceuticals (Inst); Celgene (Inst); Cellectis (Inst); Cellectis (Inst); CTI (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); MedImmune (Inst); MEI Pharma (Inst); Moffitt (Inst); Novartis (Inst); Onconova Therapeutics (Inst); Pfizer (Inst); Sunesis Pharmaceuticals (Inst); Tensha Therapeutics (Inst)
Travel, Accommodations, Expenses - Abbvie; Agios; Amgen; Amphivena; Array BioPharma; Astex Pharmaceuticals; Bayer; Celgene; Celltrion; Clovis Oncology; Eisai; Janssen; Jazz Pharmaceuticals; Novartis; Pfizer; Roche/Genentech; Sandoz; Sunesis Pharmaceuticals